Company · CIK 0001356090 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
PRECIGEN, INC. · PGEN
Insider activity reported against this company. All insider holders · Files at: OCGN, AQB, TCRT, FCSC, SNGX, ARMP, OGEN, PGEN and 1 more. On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 23, 2026 MForm 4 → | Sep 24, 4:19 pm EDT | Harry Thomasian Jr.Chief Financial Officer | 53,665 | $2.81 | $150,714 | 311,914 | — |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 23, 2026 MForm 4 → | Sep 24, 4:19 pm EDT | Harry Thomasian Jr.Chief Financial Officer | 53,665 | — | — | 520,999 | — |
Filed by this entity as an insider elsewhere — common stock
No reported common-stock activity in this period.
Filed by this entity as an insider elsewhere — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.